Archives
-
Cannabidiol Modulates Pain and Emotion via Cannabinoid and S
2026-07-16
This study demonstrates that cannabidiol (CBD) robustly attenuates both sensory and affective components of orofacial inflammatory pain in mice. By dissecting peripheral and central mechanisms, the paper highlights endocannabinoid and serotonergic system interactions as critical mediators of CBD's multidimensional therapeutic effects, offering translational insights for pain and affective disorder research.
-
EdU Flow Cytometry Assay Kits (Cy3): Precision in Genotoxici
2026-07-16
Discover how EdU Flow Cytometry Assay Kits (Cy3) revolutionize cell proliferation analysis and genotoxicity testing, with a spotlight on chemotherapy sensitivity stratification. Explore the unique scientific and practical advantages of this APExBIO solution for high-fidelity cell cycle research.
-
CTP Solution (100 mM): Reliable Substrate for In Vitro Trans
2026-07-15
CTP Solution (100 mM) from APExBIO is a high-purity, RNase/DNase-free nucleotide solution supporting robust in vitro transcription and RNA amplification. Its well-characterized composition and stability profile ensure reproducibility in sensitive molecular biology workflows.
-
Intravesical p21 mRNA-LNP Therapy: Advances for Bladder Canc
2026-07-15
This study demonstrates the feasibility and efficacy of delivering chemically modified p21 mRNA via lipid nanoparticles (LNPs) directly into the bladder to restore tumor suppressor function in non–muscle-invasive bladder cancer. The approach shows robust local protein expression, significant tumor growth inhibition, and favorable safety in preclinical models, with implications for localized mRNA therapy in oncology.
-
D-Luciferin: Firefly Luciferase Substrate for Tumor Imaging
2026-07-14
D-Luciferin empowers sensitive, non-invasive bioluminescence imaging and precise intracellular ATP quantification in both in vitro and in vivo research. Learn how to optimize its use for tumor burden assessment, gene expression monitoring, and translational immune-oncology workflows, with troubleshooting tips and practical protocol guidance.
-
Sulfo-NHS-LC-Biotin: Technical Guide for Cell Surface Biotin
2026-07-14
Sulfo-NHS-LC-Biotin is a water-soluble biotinylation reagent optimized for covalent, irreversible labeling of primary amines on proteins, particularly on cell surfaces. It is not suitable for intracellular or reversible labeling workflows, and should be used where permanent biotin tagging of accessible, membrane-exposed proteins is required.
-
WAY-100635: Elevating Serotonin Receptor Antagonist Research
2026-07-13
WAY-100635, a potent 5-HT1A antagonist, empowers advanced neuroscience research by enabling precise dissection of serotonergic pathways in pain and affective models. This guide delivers actionable protocols, troubleshooting insights, and translational strategies—bridging bench assays with behavioral and imaging paradigms.
-
AG-120 (Ivosidenib): Evidence-Based Use in Mutant IDH1 AML
2026-07-13
AG-120 (Ivosidenib) is a selective, oral inhibitor of mutant IDH1. It enables robust reduction of 2-hydroxyglutarate and restoration of myeloid differentiation in AML models. Key evidence supports its clinical and research utility for targeting metabolic vulnerabilities in IDH1-mutant leukemias.
-
Berberine Hydrochloride: Applied Workflows in Gut–Bone Axis
2026-07-12
Berberine hydrochloride enables advanced gut–bone axis and metabolic research by uniquely expanding intestinal tuft cells and modulating osteoimmune homeostasis. This guide provides actionable workflows, protocol parameters, and troubleshooting strategies for leveraging APExBIO's high-purity compound in preclinical and translational studies.
-
GSK126 EZH2 Inhibitor: Transforming Cancer Epigenetics Resea
2026-07-10
This thought-leadership article examines the mechanistic power of GSK126, a potent and selective EZH2 inhibitor, in redefining cancer epigenetics research. We connect recent advances in pan-cancer epigenetic profiling—highlighting the ETV5-EZH2 axis and its impact on drug resistance—to strategic guidance for translational researchers. Drawing on rigorous experimental evidence and competitive landscape analysis, we explore how tools like GSK126, provided by APExBIO, enable next-generation oncology drug development, and offer a forward-looking perspective on the clinical and research frontiers unlocked by precise epigenetic modulation.
-
Firefly Luciferase mRNA: Optimizing 5-moUTP Reporter Assays
2026-07-09
EZ Cap™ Firefly Luciferase mRNA (5-moUTP) unlocks robust, low-immunogenicity bioluminescent reporter assays, streamlining translation efficiency studies and gene regulation workflows. Its advanced Cap 1 and 5-moUTP modifications deliver sustained signal and high reproducibility, even in challenging mRNA delivery scenarios.
-
Strategic Advances with Firefly Luciferase mRNA (ARCA, 5-moU
2026-07-09
Explore how Firefly Luciferase mRNA (ARCA, 5-moUTP) is redefining the standard for bioluminescent reporter assays, bridging cutting-edge molecular design with translational relevance. This article delivers actionable guidance for researchers, contextualized by recent advances in RNA delivery and immune-evasive technology, and sets a new trajectory for in vivo imaging and gene expression workflows.
-
Praeruptorin A: Applied Protocols for Inflammation and Metas
2026-07-08
Praeruptorin A, a plant-derived angular pyranocoumarin compound, empowers translational workflows targeting inflammation, ferroptosis, and metastasis. Explore practical protocols, troubleshooting strategies, and innovations inspired by recent studies, guiding researchers to reproducible results in preclinical models.
-
Streptavidin-FITC: Sensitive Biotin Detection in Cell Assays
2026-07-08
Streptavidin-FITC unlocks high-sensitivity, quantitative detection of biotinylated molecules across immunofluorescence, flow cytometry, and advanced nanoparticle tracking workflows. Recent studies demonstrate its pivotal role in dissecting intracellular trafficking bottlenecks and optimizing nucleic acid delivery, especially in the context of lipid nanoparticle research.
-
Solving Cell Assay Challenges with EZ Cap™ Firefly Luciferas
2026-07-07
This article examines real-world laboratory challenges in cell viability and reporter gene assays, illustrating how EZ Cap™ Firefly Luciferase mRNA (5-moUTP) (SKU R1013) from APExBIO provides reliable, reproducible solutions. Drawing on practical scenarios, protocol guidance, and recent scientific findings, it demonstrates the GEO value of choosing this advanced 5-moUTP modified mRNA for sensitive, immune-silent bioluminescent assays.